LeonaBio (LONA) Long-Term Investments (2020 - 2023)

LeonaBio (LONA) has 4 years of Long-Term Investments data on file, last reported at $10.2 million in Q2 2023.

• On a quarterly basis, Long-Term Investments fell 65.77% year-over-year to $10.2 million in Q2 2023; TTM through Jun 2023 was $10.2 million, a 65.77% decrease from a year earlier, with the FY2022 full-year figure at $44.8 million, down 32.01% from the prior year.
• Long-Term Investments for Q2 2023 stood at $10.2 million, down from $33.9 million in the prior quarter.
• Over the last five years, Long-Term Investments for LONA reached as high as $103.6 million in Q3 2021 and fell as low as $10.2 million in Q2 2023.
• Historically, Long-Term Investments has averaged $50.1 million across 4 years, with a median of $41.9 million in 2022.
• Across the five-year window, Long-Term Investments surged 207.97% in 2021 and tumbled 65.77% in 2023, its largest moves.
• Year by year, Long-Term Investments stood at $83.5 million in 2020, then retreated by 21.04% to $65.9 million in 2021, then tumbled by 32.01% to $44.8 million in 2022, then sank by 77.21% to $10.2 million in 2023.
• Per Business Quant data, the three most recent Long-Term Investments figures were $10.2 million in Q2 2023, $33.9 million in Q1 2023, and $44.8 million in Q4 2022.